Fredrik Wermeling

11PUBLICATIONS
61CO-AUTHORS
Medical infection agents (incl. prions)AutoimmunityAutomated software engineeringMolecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 29, 2026
Dnmt3a Mutations Limit Normal and Autoreactive CD4+ T Follicular Helper Responses and Attenuate T Cell-Driven Joint Inflammation.

|Oct 03, 2025
Autoimmunity-associated DIORA1 binds the MRCK family of serine/threonine kinases and controls cell motility.

Tilen Tršelič, Nathalie Pelo, Gregoire Martin de Fremont

|May 07, 2025
Green Listed v2.0: A Web Application for Streamlined Design of Custom CRISPR Screens.

Esbjörn Henkel, Zhaojun Li, Daniel Uvehag

|Jul 30, 2024
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis.

Majid Pahlevan Kakhki, Antonino Giordano, Chiara Starvaggi Cucuzza

|Jun 05, 2024
CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation.

Jiezhen Mo, Fredrik Wermeling, Gunnar Nilsson

|Mar 16, 2023
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy.

Katrine Ingelshed, Diana Spiegelberg, Pavitra Kannan

Pageof 2

Frequent Collaborators

3 joint publications

Long Jiang

2 joint publications

Sanjaykumar V Boddul

2 joint publications

Zsolt Kasza

2 joint publications

Yunbing Shen